1. Home
  2. TAK vs LHX Comparison

TAK vs LHX Comparison

Compare TAK & LHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TAK
  • LHX
  • Stock Information
  • Founded
  • TAK 1781
  • LHX 1895
  • Country
  • TAK Japan
  • LHX United States
  • Employees
  • TAK N/A
  • LHX N/A
  • Industry
  • TAK Biotechnology: Pharmaceutical Preparations
  • LHX Industrial Machinery/Components
  • Sector
  • TAK Health Care
  • LHX Industrials
  • Exchange
  • TAK Nasdaq
  • LHX Nasdaq
  • Market Cap
  • TAK 45.8B
  • LHX 46.3B
  • IPO Year
  • TAK N/A
  • LHX N/A
  • Fundamental
  • Price
  • TAK $14.68
  • LHX $258.91
  • Analyst Decision
  • TAK
  • LHX Buy
  • Analyst Count
  • TAK 0
  • LHX 17
  • Target Price
  • TAK N/A
  • LHX $259.38
  • AVG Volume (30 Days)
  • TAK 2.3M
  • LHX 1.4M
  • Earning Date
  • TAK 07-30-2025
  • LHX 07-24-2025
  • Dividend Yield
  • TAK 3.70%
  • LHX 1.85%
  • EPS Growth
  • TAK N/A
  • LHX 36.88
  • EPS
  • TAK 0.45
  • LHX 8.43
  • Revenue
  • TAK $30,595,075,281.00
  • LHX $21,246,000,000.00
  • Revenue This Year
  • TAK $1.01
  • LHX $2.16
  • Revenue Next Year
  • TAK $1.04
  • LHX $5.60
  • P/E Ratio
  • TAK $65.09
  • LHX $30.79
  • Revenue Growth
  • TAK 7.45
  • LHX 5.39
  • 52 Week Low
  • TAK $12.80
  • LHX $193.09
  • 52 Week High
  • TAK $15.53
  • LHX $265.74
  • Technical
  • Relative Strength Index (RSI)
  • TAK 41.31
  • LHX 68.48
  • Support Level
  • TAK $14.93
  • LHX $250.02
  • Resistance Level
  • TAK $15.14
  • LHX $258.01
  • Average True Range (ATR)
  • TAK 0.15
  • LHX 4.19
  • MACD
  • TAK -0.06
  • LHX 0.23
  • Stochastic Oscillator
  • TAK 11.86
  • LHX 87.08

About TAK Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of)

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.6 trillion in fiscal 2024. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with over 50% derived from the US, 20% from Japan, 20% from Europe and Canada.

About LHX L3Harris Technologies Inc.

L3Harris Technologies provides products primarily for the command, control, communications, computers, intelligence, surveillance, and reconnaissance, or C4ISR, market. The firm produces uncrewed aerial vehicles, sensors, and avionics, provides military and commercial training services, and maintains the US Federal Aviation Administration's communications infrastructure. In July 2023, the company acquired Aerojet Rocketdyne, a key supplier of rocket motors used in the space industry and to propel munitions.

Share on Social Networks: